Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001884478 | SCV002152616 | uncertain significance | Aortic aneurysm, familial thoracic 4 | 2022-07-18 | criteria provided, single submitter | clinical testing | Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. ClinVar contains an entry for this variant (Variation ID: 1388276). This sequence change replaces valine, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 1289 of the MYH11 protein (p.Val1289Leu). This variant is present in population databases (rs763285173, gnomAD 0.006%). This variant has not been reported in the literature in individuals affected with MYH11-related conditions. |
Ambry Genetics | RCV004039073 | SCV005015555 | uncertain significance | Familial thoracic aortic aneurysm and aortic dissection | 2024-01-02 | criteria provided, single submitter | clinical testing | The c.3844G>C (p.V1282L) alteration is located in exon 28 (coding exon 27) of the MYH11 gene. This alteration results from a G to C substitution at nucleotide position 3844, causing the valine (V) at amino acid position 1282 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |